C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) A01N 43/04 (2006.01) C07H 21/02 (2006.01) C07H 21/04 (2006.01) C12N 15/63 (2006.01) C12N 15/88 (2006.01) C12P 19/34 (2006.01)
Patent
CA 2580504
Described herein are gap-widened antisense oligonucleotides having improved therapeutic index as compared to 5-10-5 MOE gapmer antisense oligonucleotides of the same sequence. Also described are methods of reducing a target RNA in an animal using the gap-widened antisense oligonucleotides of the present invention. Further, are methods for selecting a gap-widened antisense oligonucleotides.
L'invention concerne des oligonucléotides antisens élargis par un espace (<= gap >=) à indice thérapeutique amélioré par rapport aux oligonucléotides antisens de type espacemère (<= gapmer >=) 5-10-5 MOE de la même séquence. On décrit aussi des procédés de réduction d'ARN cible chez un animal faisant appel aux oligonucléotides élargis en question, et enfin des procédés de sélection pour ce type d'oligonucléotide.
Bhanot Sanjay
Monia Brett P.
Siwkowski Andrew M.
Gowling Lafleur Henderson Llp
Isis Pharmaceuticals Inc.
LandOfFree
Enhanced antisense oligonucleotides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enhanced antisense oligonucleotides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhanced antisense oligonucleotides will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1771979